{"id":"NCT01803555","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","briefTitle":"Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER®","officialTitle":"A 12-Week Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX(R) 160/4.5 mcg Inhalation Powder Versus SYMBICORT(R) TURBOHALER(R) 200/6 mcg in Adult and Adolescent Patients With Persistent Asthma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-07-04","primaryCompletion":"2014-03-20","completion":"2014-03-20","firstPosted":"2013-03-04","resultsPosted":"2023-12-08","lastUpdate":"2023-12-08"},"enrollment":605,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"Budesonide/Formoterol SPIROMAX®","otherNames":[]},{"type":"DRUG","name":"SYMBICORT® TURBOHALER®","otherNames":[]},{"type":"DRUG","name":"SYMBICORT placebo","otherNames":[]},{"type":"DRUG","name":"SPIROMAX Placebo","otherNames":[]}],"arms":[{"label":"BF Spiromax","type":"EXPERIMENTAL"},{"label":"Symbicort Turbohaler","type":"ACTIVE_COMPARATOR"}],"summary":"The primary objective of the study is to establish whether budesonide/formoterol fumarate dihydrate (BF) Spiromax 160/4.5 micrograms (mcg) is as effective as Symbicort Turbohaler 200/6 mcg administered twice daily in participants with persistent asthma.","primaryOutcome":{"measure":"Change From Baseline in Weekly Average of Daily Trough (Predose and Pre-rescue Bronchodilator) Morning (AM) Peak Expiratory Flow (PEF) Over the 12-Week Treatment Period","timeFrame":"Baseline, Weeks 1 to 12 (averaged over 12 weeks)","effectByArm":[{"arm":"BF Spiromax","deltaMin":18.839,"sd":2.754},{"arm":"Symbicort Turbohaler","deltaMin":21.796,"sd":2.745}],"pValues":[{"comp":"OG000 vs OG001","p":"0.3387"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":5},"locations":{"siteCount":114,"countries":["Austria","Belgium","Czechia","Denmark","Finland","France","Germany","Hungary","Israel","Italy","Netherlands","Poland","Russia","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["26987997"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":303},"commonTop":["Nasopharyngitis","Headache"]}}